Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Authors:
- Romain LévyRLRomain Lévy
- Florian GotheFGFlorian Gothe
- Mana MomenilandiMMMana Momenilandi
- Thomas MaggTMThomas Magg
- Marie MaternaMMMarie Materna
- Philipp PetersPPPhilipp Peters
- Johannes RaedlerJRJohannes Raedler
- Quentin PhilippotQPQuentin Philippot
- Anita Lena Rack-HochARAnita Lena Rack-Hoch
- David LanglaisDLDavid Langlais
- Mathieu BourgeyMBMathieu Bourgey
- Anna-Lisa LanzALAnna-Lisa Lanz
Open Access
- 14 December 2022
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (2)
Abstract
Patients with inherited CARMIL2 or CD28 deficiency have defective T cell CD28 signaling, but their immunological and clinical phenotypes remain largely unknown. We show that only one of three CARMIL2 isoforms is produced and functional across leukocyte subsets. Tested mutant CARMIL2 alleles from 89 patients and 52 families impair canonical NF-κB but not AP-1 and NFAT activation in T cells stimulated via CD28. Like CD28-deficient patients, CARMIL2-deficient patients display recalcitrant warts and low blood counts of CD4+ and CD8+ memory T cells and CD4+ TREGs. Unlike CD28-deficient patients, they have low counts of NK cells and memory B cells, and their antibody responses are weak. CARMIL2 deficiency is fully penetrant by the age of 10 yr and is characterized by numerous infections, EBV+ smooth muscle tumors, and mucocutaneous inflammation, including inflammatory bowel disease. Patients with somatic reversions of a mutant allele in CD4+ T cells have milder phenotypes. Our study suggests that CARMIL2 governs immunological pathways beyond CD28.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Deutsche Forschungsgemeinschaft (GO2955/1-1)
- Care-for-Rare Foundation (160073)
- Munich Clinician Scientist Program
- German Center for Infection Research (TTU 07.909)
- Else Kröner-Fresenius Stiftung (2017_A110)
- German Federal Ministry of Education and Research (01GM1910C)
- Fonds de la Recherche Québec-Santé
- Leona M. and Harry B. Helmsley Charitable Trust
- Howard Hughes Medical Institute
- Rockefeller University
- St. Giles Foundation
- National Institutes of Health (R01AI088364, R01AI163029)
- National Center for Advancing Translational Sciences
- National Institutes of Health (UL1 TR001866)
- Mercatus Center at George Mason University
- Emergent Ventures
- Yale Center for Mendelian Genomics
- National Human Genome Research Institute (UM1HG006504, U24HG008956)
- Yale High-Performance Computing Center (S10OD018521)
- Fisher Center for Alzheimer’s Research Foundation
- Meyer Foundation
- JPB Foundation
- French National Research Agency (ANR-10-IAHU-01)
- Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID)
- French Foundation for Medical Research (EQU201903007798)
- ANR CARMIL2 (ANR-21-CE15-0034)
- Square Foundation
- Grandir–Fonds de Solidarité pour l’Enfance
- French Society of Dermatology
- University of Paris
- Fulbright
This publication has 52 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Regulation of NF‐κB by the CARD proteinsImmunological Reviews, 2012
- Regulation of PKC-θ function by phosphorylation in T cell receptor signalingFrontiers in Immunology, 2012
- A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28Nature Immunology, 2011
- Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1Cold Spring Harbor Perspectives in Biology, 2010
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and ImmunityImmunity, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Phosphorylation of CARMA1 Plays a Critical Role in T Cell Receptor-Mediated NF-κB ActivationImmunity, 2005
- A requirement for CARMA1 in TCR-induced NF-κB activationNature Immunology, 2002